Check-Cap Ltd. (7CC.F)
- Previous Close
2.0200 - Open
2.0800 - Bid 2.1000 x 85000
- Ask 2.1600 x 80000
- Day's Range
2.0800 - 2.0800 - 52 Week Range
1.1500 - 4.2400 - Volume
80 - Avg. Volume
1 - Market Cap (intraday)
12.459M - Beta (5Y Monthly) 0.12
- PE Ratio (TTM)
-- - EPS (TTM)
-2.8100 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
2.50
Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. Check-Cap Ltd. was incorporated in 2004 and is based in Isfiya, Israel.
www.check-cap.com85
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 7CC.F
Performance Overview: 7CC.F
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 7CC.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 7CC.F
Valuation Measures
Market Cap
12.46M
Enterprise Value
-13.68M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
0.48
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
0.82
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-28.62%
Return on Equity (ttm)
-48.74%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-17.62M
Diluted EPS (ttm)
-2.8100
Balance Sheet and Cash Flow
Total Cash (mrq)
28.07M
Total Debt/Equity (mrq)
0.11%
Levered Free Cash Flow (ttm)
-12.62M
Research Analysis: 7CC.F
Company Insights: 7CC.F
7CC.F does not have Company Insights